216 related articles for article (PubMed ID: 30507008)
21. Effect of cationic lipid in cationic liposomes on siRNA delivery into the lung by intravenous injection of cationic lipoplex.
Hattori Y; Nakamura M; Takeuchi N; Tamaki K; Shimizu S; Yoshiike Y; Taguchi M; Ohno H; Ozaki KI; Onishi H
J Drug Target; 2019 Feb; 27(2):217-227. PubMed ID: 30024300
[TBL] [Abstract][Full Text] [Related]
22. Silencing of HMGA2 promotes apoptosis and inhibits migration and invasion of prostate cancer cells.
Shi Z; Wu D; Tang R; Li X; Chen R; Xue S; Zhang C; Sun X
J Biosci; 2016 Jun; 41(2):229-36. PubMed ID: 27240983
[TBL] [Abstract][Full Text] [Related]
23. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of HMGA2 by Small Interfering RNA Affects the Survival, Migration, and Apoptosis of Prostate Cancer Cell Line.
Khajouee S; Baghbani E; Mohammadi A; Mansoori B; Shanehbandi D; Hajiasgharzadeh K; Baradaran B
Adv Pharm Bull; 2022 Mar; 12(2):398-403. PubMed ID: 35620335
[No Abstract] [Full Text] [Related]
25. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
[TBL] [Abstract][Full Text] [Related]
26. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
Khatri N; Baradia D; Vhora I; Rathi M; Misra A
AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
[TBL] [Abstract][Full Text] [Related]
27. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
28. PEGylated DC-Chol/DOPE cationic liposomes containing KSP siRNA as a systemic siRNA delivery Carrier for ovarian cancer therapy.
Lee J; Ahn HJ
Biochem Biophys Res Commun; 2018 Sep; 503(3):1716-1722. PubMed ID: 30049442
[TBL] [Abstract][Full Text] [Related]
29. [The effects of lentivirus-mediated RNA interference silencing HMGA2 on proliferation and expressions of cyclin B2 and cyclin A2 in HL-60 cells].
Liu WD; Tan L; Xiong XF; Liang YP; Tan H
Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):448-52. PubMed ID: 22967378
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer.
Cai J; Shen G; Liu S; Meng Q
Tumour Biol; 2016 Jan; 37(1):699-707. PubMed ID: 26242267
[TBL] [Abstract][Full Text] [Related]
31. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
[TBL] [Abstract][Full Text] [Related]
32. HMGA2 regulates acute myeloid leukemia progression and sensitivity to daunorubicin via Wnt/β-catenin signaling.
Yang S; Gu Y; Wang G; Hu Q; Chen S; Wang Y; Zhao M
Int J Mol Med; 2019 Aug; 44(2):427-436. PubMed ID: 31173171
[TBL] [Abstract][Full Text] [Related]
33. Efficacious gene silencing in serum and significant apoptotic activity induction by survivin downregulation mediated by new cationic gemini tocopheryl lipids.
Kumar K; Maiti B; Kondaiah P; Bhattacharya S
Mol Pharm; 2015 Feb; 12(2):351-61. PubMed ID: 25438085
[TBL] [Abstract][Full Text] [Related]
34. The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity.
Kaur H; Hütt-Cabezas M; Weingart MF; Xu J; Kuwahara Y; Erdreich-Epstein A; Weissman BE; Eberhart CG; Raabe EH
J Neuropathol Exp Neurol; 2015 Feb; 74(2):177-85. PubMed ID: 25575139
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway.
Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB
J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837
[TBL] [Abstract][Full Text] [Related]
36. A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy.
Baradaran B; Mohammadi A; Shamekhi S; Majidazar N; Dilmaghani A; Soofiyani SR; McMillan NA; Lotfipour F; Hallaj-Nezhadi S
Drug Deliv Transl Res; 2022 Jun; 12(6):1508-1520. PubMed ID: 34322851
[TBL] [Abstract][Full Text] [Related]
37. In vitro evaluation of optimized liposomes for delivery of small interfering RNA.
Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S
J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056
[TBL] [Abstract][Full Text] [Related]
38. High Glucose Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in A20 Murine Diffuse Large B-Cell Lymphoma Cells Through Increased Expression of High Mobility Group AT-Hook 2 (HMGA2).
Wang Y; Tan J; Wu H; Yi C
Med Sci Monit; 2019 May; 25():3860-3868. PubMed ID: 31124542
[TBL] [Abstract][Full Text] [Related]
39. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
40. PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity.
Belletti D; Tosi G; Forni F; Lagreca I; Barozzi P; Pederzoli F; Vandelli MA; Riva G; Luppi M; Ruozi B
Eur J Pharm Biopharm; 2016 Feb; 99():7-17. PubMed ID: 26625717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
